Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11 infusion OF MSC----1件: 51 💬
21.5 X 10^6 UC-MSC + CM----1件: 90 💬
32 infusions OF MSC----1件: 51 💬
4Allogeneic adipose tissue-derived MSC----1件: 36 💬
5Autologous MSC-NTF cells1件: Debamestrocel (AUTOLOGOUS MSC-NTF)---1件: 2 💬
6GMP compliant-BM-MSC derived sevs----1件: 90 💬
7HUC-MSC----1件: 218 💬
8HUC-MSC + dmards----1件: 46 💬
9HUC-MSC suspension----1件: 46 💬
10HUC-MSC-SEV-001 nasal drops----2件: 6, 17 💬
11Human allogeneic WJ-mscs----1件: 36 💬
12Human umbilical cord derived MSC transplantation FOR SLE----1件: 49 💬
13Human umbilical CORD-derived mscs----1件: 271 💬
14Human umbilical CORD-derived mscs and cyclosporin A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
15Injection OF umbilical cord derived mscs----1件: 6 💬
16Intrathecal administration OF autologous MSC-NP----1件: 13 💬
17Intrathecal MSC-NP injection----1件: 13 💬
18Intravenous administration OF 1 million OF MSC----1件: 2 💬
19Intravenous administration OF 2 million OF MSC----1件: 2 💬
20Intravenous administration OF 4 million OF MSC----1件: 2 💬
21Intravenous infusion OF mscs----1件: 271 💬
22Mesenchymal stromal cells (MSC) FOR infusion1件: Human Umbilical Cord Mesenchymal Stem Cells (WJ-MSCs)---1件: 96 💬
23MSC----5件: 51, 60, 96, 97, 271 💬
24MSC injection 01----1件: 96 💬
25MSC injection 02----1件: 96 💬
26MSC treatment----1件: 49 💬
27MSC treatment 01----1件: 96 💬
28MSC treatment 02----1件: 96 💬
29MSC+ATG----1件: 60 💬
30MSC-AFP----1件: 96 💬
31MSC-exos nebulization therapy----1件: 50 💬
32MSC2015----1件: 13 💬
33MSC2304479A----1件: 13 💬
34MSC2304480A----1件: 13 💬
35MSC2304481A----1件: 13 💬
36MSC2304482A----1件: 13 💬
37MSC2358825A----1件: 13 💬
38MSC2364447C----2件: 13, 49 💬
39MSC2491529A----1件: 13 💬
40Msc_ntf cells transplantation BY multiple intramuscular injections AT 24 separate sites, IN addition TO A single intrathechal injection into THE CSF----1件: 2 💬
41Mscs----2件: 13, 228 💬
42NW-1015E, EMD 1195686, MSC2191632B----1件: 6 💬
43Only 1 ARM: treatment with MSC-AFP----1件: 96 💬
44ONO-4641/ MSC2430913A----1件: 13 💬
45ONO-4641/MSC2430913A----1件: 13 💬
46Ossium VBM-MSC----1件: 96 💬
47PF2020-cell (UC-mscs) - allogeneic human umbilical cord mesenchymal stem cells----1件: 96 💬
48Single dose OF UC-mscs----1件: 49 💬
49Suspension OF human autologous MSC 3P IN 1,5 ML----1件: 2 💬
50Suspension OF human autologous MSC 3P IN 1.5 ML----1件: 2 💬
51TC-MSC----2件: 36, 107 💬
52UC-MSC+dmards----1件: 46 💬
53UC-mscs1件: Human Umbilical Cord Mesenchymal Stem Cells (WJ-MSCs)---1件: 46 💬
54UC-mscs BY peripheral intravenous infusion1件: Human Umbilical Cord Mesenchymal Stem Cells (WJ-MSCs)---1件: 96 💬
55Umbilical cord derived mesenchymal stem cell (UC -MSC) transplantation----2件: 93, 296 💬